Recombinant Mouse Potassium voltage-gated channel subfamily C member 4 (Kcnc4)

What is Kcnc4 and what is its molecular structure?

Kcnc4 (Kv3.4) is an integral membrane protein belonging to the Kv3 subfamily of voltage-gated potassium channels. The protein consists of 635 amino acid residues and contains six transmembrane segments (S1-S6) with a voltage-sensor domain located in the S4 segment . The channel forms either homotetrameric potassium channels (composed of four identical Kcnc4 subunits) or heterotetrameric channels (containing different Kv3 subfamily members) . The channel's structure enables its primary function: the regulation of potassium ion transport across the cell membrane in response to voltage changes.

Unlike other Kv3 subfamily members that regulate slow-inactivating delayed rectifier-type currents, Kcnc4 is involved in the production of fast-inactivating A-type currents . This functional distinction is critical for its physiological roles.

What are the primary tissue expression patterns of mouse Kcnc4?

Mouse Kcnc4 is primarily expressed in the brain and kidney . Within the nervous system, it shows significant expression in dorsal root ganglion (DRG) neurons, where it regulates action potential repolarization and influences nociceptive signaling . The channel also plays roles in excitatory synaptic transmission in the spinal cord .

How does Kcnc4 function in normal physiology?

Kcnc4 functions as a voltage-gated potassium channel that regulates the transportation of potassium ions across the membrane according to their electrochemical gradient . The channel changes its conformation between open and closed states in response to membrane voltage differences, thereby controlling potassium ion permeability in excitable membranes .

In skeletal muscle, Kcnc4-containing channels regulate the resting potential of muscle cells . In neurons, particularly nociceptors, Kcnc4 governs action potential repolarization, influencing the duration and frequency of action potentials . This function is critical for proper neuronal signaling and synaptic transmission.

What viral vector approaches are effective for Kcnc4 manipulation in research?

For manipulation of Kcnc4 expression in research settings, Adeno-Associated Virus (AAV) vectors have proven highly effective. Commercially available mouse Kcnc4 AAV particles, such as serotype AAV-2 with Myc-DDK tags, provide researchers with validated tools for overexpression studies . These vectors typically achieve viral titers of approximately 10^13 TU/mL, ensuring efficient transduction of target cells .

For experimental design, researchers should consider:

• Promoter selection: The human synapsin (hSyn) promoter drives neuron-specific expression and is commonly used for Kcnc4 studies in the nervous system

• Reporter co-expression: Vectors incorporating IRES elements enable bicistronic expression of Kcnc4 and reporters like GFP, facilitating identification of transduced cells

• Transduction efficiency: For DRG neurons, AAV6 serotype has demonstrated effective transduction, with expression detectable 6 days post-infection

When evaluating transduction success, a combination of fluorescence microscopy (for reporter expression) and patch clamp electrophysiology (for functional validation) provides complementary information about both expression and channel function .

How can researchers generate and utilize Kcnc4 mutants to study channel function?

Several functionally distinct Kcnc4 mutants have been developed to investigate specific aspects of channel function:

These mutants can be generated using QuikChange mutagenesis based on the rat Kcnc4 (rKv3.4) wild-type sequence and subsequently packaged into AAV vectors . When expressed in neurons, they differentially affect action potential (AP) properties: Kv3.4-DN produces the longest AP duration, Kv3.4-PM generates the shortest, while Kv3.4-WT and Kv3.4-PN yield intermediate durations .

For patch-clamp electrophysiology experiments, these mutants exhibit similar voltage dependence of activation but differ in their inactivation kinetics, making them valuable tools for investigating how specific channel properties influence neuronal excitability .

What is the role of phosphorylation in Kcnc4 function and how can it be studied?

Kcnc4 function is significantly modulated by protein kinase C (PKC)-mediated phosphorylation, particularly at four key serine residues (S8, S9, S15, S21) in the N-terminal inactivation domain (NTID) . This phosphorylation dramatically alters channel inactivation properties and consequently affects action potential repolarization in neurons.

To study phosphorylation effects, researchers can:

• Utilize phosphomimic (PM) mutants (S8D, S9D, S15D, S21D) that substitute serine residues with negatively charged aspartic acid, mimicking the phosphorylated state

• Compare with phosphonull (PN) mutants (S8A, S9A, S15A, S21A) where serines are replaced with non-phosphorylatable alanines

• Conduct voltage-clamp and current-clamp analyses to correlate phosphorylation state with channel kinetics and action potential properties

These approaches have revealed that PKC phosphorylation creates a tunable mechanism for regulating action potential repolarization rates and durations in dorsal root ganglion neurons, with significant implications for neuronal signaling .

How is Kcnc4 implicated in cancer pathophysiology?

Abnormal expression of Kcnc4 has been implicated in several cancer types, particularly oral and head and neck squamous cell carcinomas . The early occurrence and high prevalence of abnormal Kcnc4 expression in oral leucoplakias support its role in tumorigenesis rather than in tumor progression or disease outcome .

Research methodologies for investigating Kcnc4 in cancer include:

• Expression analysis in pre-cancerous and cancerous tissues compared to normal controls

• Correlation of expression levels with clinical staging and patient outcomes

• Functional studies examining how Kcnc4 modulation affects cancer cell proliferation, apoptosis, and cell cycle progression

Studies have shown that Kcnc4 plays a role in malignant transformation, suggesting it could serve as a biomarker for cancer risk assessment . Additionally, research indicates that Kcnc4 electrosignaling may regulate cell cycle and survival in irradiated leukemia cells, and Kcnc4 blockade can induce cell cycle arrest after G2/M phase completion in vascular smooth muscle cells .

What is known about Kcnc4's role in neurological disorders?

Kcnc4 has been implicated in several neurological conditions:

• Alzheimer's Disease: Kcnc4 overexpression is observed in both early and advanced stages of Alzheimer's disease . This altered expression may contribute to neuronal dysfunction and apoptotic processes.

• Neuropathic Pain: Kcnc4 channel dysregulation has been identified as a peripheral mechanism of pain sensitization following spinal cord injury (SCI) . Research suggests that Kcnc4-based therapeutic interventions may have potential for treating post-SCI pain.

For studying Kcnc4 in neurological disorders, researchers commonly employ:

• Animal models with altered Kcnc4 expression or function

• Electrophysiological recordings to assess channel activity in disease states

• Pharmacological interventions targeting Kcnc4 to evaluate therapeutic potential

• Histological and molecular analyses of Kcnc4 expression patterns in affected tissues

What are the key considerations for patch-clamp studies of recombinant Kcnc4?

When conducting patch-clamp electrophysiology studies with recombinant mouse Kcnc4, researchers should consider:

• Expression System Selection:

  • Primary neuronal cultures (particularly DRG neurons) provide a physiologically relevant background

  • Duration of expression: For AAV-mediated expression in DRG neurons, reliable expression and function are typically observed 6-9 days post-infection

• Electrophysiological Parameters:

  • Voltage-clamp protocols should assess activation, inactivation, and recovery from inactivation

  • Current-clamp recordings should evaluate effects on action potential waveforms, particularly repolarization phase

  • Temperature control is critical as channel kinetics are temperature-dependent

• Analysis Approaches:

  • Quantify both current amplitude and kinetic parameters (activation time constants, inactivation rates)

  • For action potentials, measure duration at half-maximal amplitude, repolarization rate, and afterhyperpolarization

• Controls:

  • GFP-only expression vectors serve as important controls for viral transduction effects

  • Non-transduced neurons provide baseline comparisons for endogenous channel activity

How can researchers optimize recombinant Kcnc4 protein production for structural and functional studies?

For production of soluble and functional Kcnc4 protein:

• Expression System Considerations:

  • Mammalian expression systems often yield properly folded and post-translationally modified channels

  • Insect cell systems may provide higher yields while maintaining functional properties

  • Cell-free systems can be employed for rapid screening of mutants

• Purification Strategies:

  • Affinity tags such as Myc-DDK (available in commercial constructs) facilitate purification

  • Detergent selection is critical for maintaining channel structure and function during solubilization

  • Size exclusion chromatography can help isolate tetrameric channel complexes

• Functional Verification:

  • Reconstitution into lipid bilayers or liposomes for electrophysiological characterization

  • Binding assays with known channel blockers to confirm proper folding

  • Structural analysis through techniques such as cryo-electron microscopy

Commercial platforms like the MagicTM membrane protein production platform offer versatile options for obtaining soluble and functional target proteins for various research applications .

What emerging technologies show promise for advancing Kcnc4 research?

Several cutting-edge approaches hold potential for advancing our understanding of Kcnc4 function:

• CRISPR/Cas9 Gene Editing:

  • Generation of cell lines and animal models with precisely engineered mutations

  • Knockin of fluorescent tags for live imaging of channel trafficking and localization

  • Creation of conditional knockout models for tissue-specific studies

• Optogenetic and Chemogenetic Approaches:

  • Development of light-sensitive or ligand-sensitive Kcnc4 variants for acute modulation

  • Combination with electrophysiology for real-time correlation of channel activity with neuronal function

• Computational Modeling:

  • Molecular dynamics simulations to understand structural determinants of channel gating

  • Integration of channel properties into neuronal network models to predict system-level effects

• High-Throughput Screening:

  • Development of assays suitable for identifying novel Kcnc4 modulators

  • Phenotypic screening in disease models to identify therapeutic candidates

These emerging approaches, combined with established methodologies, will likely yield significant insights into Kcnc4 function in health and disease.